Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

  • STATUS
    Recruiting
  • participants needed
    350
  • sponsor
    Q-Med AB
Send
Updated on 19 February 2024
See if I qualify

Summary

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Details
Condition Lateral Canthal Lines, Glabellar Frown Lines (GL)
Age 18years - 100years
Treatment Placebo, botulinum toxin neuromodulator
Clinical Study IdentifierNCT04247074
SponsorQ-Med AB
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Male or female 18 years of age or older
Moderate to severe LCL at maximum smile as assessed by the Investigator
Moderate to severe LCL at maximum smile as assessed by the subject
Moderate to severe GL at maximum frown as assessed by the Investigator
Moderate to severe GL at maximum frown as assessed by the subject

Exclusion Criteria

Previous use of any Botulinum toxin in facial areas within 9 months prior to study treatment
Female who is pregnant, breast feeding, or intends to conceive a child during the study
Known allergy or hypersensitivity to any component of the investigational product (QM1114-DP)
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.